Paper41031024
No Evidence of Direct Activation of Human Neutrophil Responses by Multivalent Prefusion Trimeric SARS-CoV-2 Spike Protein ex vivo.
Fortin A and 10 others. bioRxiv, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. No Evidence of Direct Activation of Human Neutrophil Responses by Multivalent Prefusion Trimeric SARS-CoV-2 Spike Protein ex vivo. Papers, record 41031024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41031024
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- No Evidence of Direct Activation of Human Neutrophil Responses by Multivalent Prefusion Trimeric SARS-CoV-2 Spike Protein ex vivo.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Updated in | 41160626 | No evidence of direct activation of human neutrophil responses by multivalent prefusion trimeric SARS-CoV-2 Spike protein ex vivo. | https://conductscience.org/library/papers/41160626 |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35933275 | Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China. | Vaccine | 2022 | https://conductscience.org/library/papers/35933275 | PubMed |
| 2 | 32155444 | Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. | Cell | 2020 | https://conductscience.org/library/papers/32155444 | PubMed |
| 3 | 23514610 | Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps. | J Inflamm (Lond) | 2013 | https://conductscience.org/library/papers/23514610 | PubMed |
| 4 | 32303591 | Cytokine release syndrome in severe COVID-19. | Science | 2020 | https://conductscience.org/library/papers/32303591 | PubMed |
| 5 | 36766808 | Immune Cells Release MicroRNA-155 Enriched Extracellular Vesicles That Promote HIV-1 Infection. | Cells | 2023 | https://conductscience.org/library/papers/36766808 | PubMed |
| 6 | 26862747 | A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3. | J Vis Exp | 2016 | https://conductscience.org/library/papers/26862747 | PubMed |
| 7 | 36963565 | Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19. | Clin Microbiol Infect | 2023 | https://conductscience.org/library/papers/36963565 | PubMed |
| 8 | 32946139 | IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: A crucial role for FcgRI in the generation of reactive oxygen species. | FASEB J | 2020 | https://conductscience.org/library/papers/32946139 | PubMed |
| 9 | 30758246 | The Neutrophil's Role During Health and Disease. | Physiol Rev | 2019 | https://conductscience.org/library/papers/30758246 | PubMed |
| 10 | 34709564 | SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia. | Mol Neurobiol | 2022 | https://conductscience.org/library/papers/34709564 | PubMed |
| 11 | 34400651 | Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/34400651 | PubMed |
| 12 | 32805734 | Structures and distributions of SARS-CoV-2 spike proteins on intact virions. | Nature | 2020 | https://conductscience.org/library/papers/32805734 | PubMed |
| 13 | 39096925 | Long COVID: a clinical update. | Lancet | 2024 | https://conductscience.org/library/papers/39096925 | PubMed |
| 14 | 38395697 | SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. | Immunity | 2024 | https://conductscience.org/library/papers/38395697 | PubMed |
| 15 | 32439197 | COVID-19 and Multiorgan Response. | Curr Probl Cardiol | 2020 | https://conductscience.org/library/papers/32439197 | PubMed |
| 16 | 33979301 | High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33979301 | PubMed |
| 17 | 36460710 | SARS-CoV-2 spike protein induces a differential monocyte activation that may contribute to age bias in COVID-19 severity. | Sci Rep | 2022 | https://conductscience.org/library/papers/36460710 | PubMed |
| 18 | 32597954 | Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. | Blood | 2020 | https://conductscience.org/library/papers/32597954 | PubMed |
| 19 | 33097791 | A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone. | Sci Rep | 2020 | https://conductscience.org/library/papers/33097791 | PubMed |
| 20 | 38604216 | Plasma-based antigen persistence in the post-acute phase of COVID-19. | Lancet Infect Dis | 2024 | https://conductscience.org/library/papers/38604216 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VTN | 7448 | PubTator's text mining | https://conductscience.org/library/genes/7448 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41031024
GET https://conductscience.org/api/papers/v1/41031024/references?page=2